Delivery Order SPE2DR25D3501-SPE2DR26FM2ZZ
Award Date 1/23/26
Potential Completion Date 2/13/26
Potential Value $7.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at approximately $82,043 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (100-count units) on January 13, 2026, with an ultimate completion date of February 4, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc.,...
- The Defense Logistics Agency awarded a delivery order valued at $19,176.36 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) on January 23, 2026, with a completion date of February 13, 2026. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The contractor's place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp is a...
- The Defense Logistics Agency awarded a delivery order valued at $12,993.03 to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (quantity: 28 units). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of December 12, 2025. The pharmaceutical supply will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Revlimid 25 mg capsules (100 count) with a ceiling value of $104,975.62. This firm fixed-price delivery order, which is expected to be completed by October 15, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $25,840.56 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) under a firm fixed price contract. The award, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and will fulfill...
- The Defense Logistics Agency awarded a $19,176.36 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Revlimid 10 mg capsules (28-count units). This competitively awarded, firm fixed price delivery order is scheduled for completion by January 21, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award was not designated as a set-aside contract. This delivery order is issued under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a $19.2K delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 7, 2026, for the supply of Revlimid 10 mg capsules in quantities of 28 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 29, 2026. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 8, 2025, for the supply of Revlimid 5 mg capsules (28-count) with a ceiling value of $12,329.15. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 30, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Revlimid 5 mg capsules (100 count) with a ceiling value of $120,863.94. This firm fixed price delivery order is scheduled for completion by January 12, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's established capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Revlimid 25 mg capsules (100-count units) under a firm fixed-price contract valued at $52,487.80, with completion expected by September 26, 2025. This non-competitive delivery order represents a continuation of the company's critical role as a pharmaceutical supplier to the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...